Health Catalyst (HCAT) Tops Q2 Earnings and Revenue Estimates
ZacksHealth Catalyst (HCAT) delivered earnings and revenue surprises of 33.33% and 1.21%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?